Costco Now Offers Ozempic and Wegovy for $499, Expanding Access to Popular Diabetes and Obesity Drugs
Costco has started offering Ozempic and Wegovy, popular GLP-1 drugs for obesity treatment and diabetes management, at its pharmacies nationwide. The four-week supply costs $499 out of pocket, matching Novo Nordisk's direct-to-consumer price and that of other major retailers like CVS and Walmart. This move aims to provide affordable access to authentic medications, competing against cheaper alternatives.
Beginning Friday, over 600 Costco pharmacies across the U.S. will provide discounted prescriptions for Ozempic and Wegovy. Costco members with a prescription will pay $499 for a one-month supply, with additional rewards for Executive members and Costco Citibank credit card holders. This price is consistent with Novo Nordisk's direct-to-consumer website and major retailers.
While Costco's addition improves access, it doesn't fully address insurance coverage and cost issues. Dr. Rekha Kumar notes that major insurance companies, including Medicare, Medicaid, and private plans, may offer cost advantages or even full coverage for eligible patients. However, coverage varies significantly by plan, and specific out-of-pocket costs or restrictions are common. Patients should check directly with their provider for details on their coverage and copay requirements.
Ozempic and Wegovy have shown potential beyond weight management and diabetes control. Studies suggest they may reduce stroke risk, treat liver disease, and protect heart health.
Costco's entry into the GLP-1 drug market provides a consistent, affordable pricing option for patients seeking authentic Ozempic and Wegovy. With around 1 in 8 adults having used a GLP-1 agonist, this move could significantly impact access to these medications. However, insurance coverage and cost issues remain complex and vary by individual plans.
